study | Audio Medica – Medical Audio News Interviews & Podcasts

Blind For Blindness: Preventing Childhood Blindness+

28th May 2008

Hessom Razavi, Puneet Sayal, Claire Gilbert

Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine
Eye doctor Hessom Razavi volunteered to go about his usual studies at the London School blindfold for 24 hours to

…

Read More+

Bivalirudin For Angioplasty: Expensive Heparin?+

30th April 2008

Tony Gershlick

Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the

…

Read More+

Never Too Old For Hypertension Treatment!+

8th April 2008

nigel beckett Never Too Old For Hypertension Treatment!

Nigel Beckett
nick boon Never Too Old For Hypertension Treatment!

Nick Boon

Nigel Beckett, Imperial College, London
COMMENT: Nick Boon, British Cardiovascular Society, London
Even very old patients benefit greatly if you treat their hypertension. This is the finding of the randomized HYVET study of 4,000 patients with

…

Read More+

Bevacizumab: New Standard for Non-Small Cell Lung Cancer?+

16th March 2008

christian manegold Bevacizumab: New Standard for Non Small Cell Lung Cancer?

Christian Manegold
nicholas thatcher Bevacizumab: New Standard for Non Small Cell Lung Cancer?

Nick Thatcher

Christian Manegold, Heidelberg University Medical Center, Manheim
Nick Thatcher, Christie Hospital, Manchester

Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question

…

Read More+

Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer+

16th March 2008

Robert Pirker

ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.

…

Read More+

Lung Cancer Screening: Wait for Prospective Study Findings!+

16th March 2008

Ugo Pastorino

UGO PASTORINO , Istituto Nazionale Tumori, Milan
Even the most sophisticated and powerful detection method for lung cancer detection, spiral CT, is still unproven in the context of mass screening for lung cancer. At the conference in Turin,

…

Read More+

London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths+

17th January 2008

Zulfiqar Bhutta

Reference: The Lancet, Maternal and Child Undernutrition Special Series
With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta

…

Read More+

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability+

4th January 2008

Peter Tyrer

REFERENCE: Lancet 371:57 January 5, 2008
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as

…

Read More+

Live Report from ASH:
Ibritumomab Provides Benefit in Patients with Follicular Lymphoma+

11th December 2007

anton hagenbeek Live Report from ASH:<br />Ibritumomab Provides Benefit in Patients with Follicular Lymphoma” src=”http://www.audiomedica.com/img/asco/071209/anton_hagenbeek.jpg” /<br /> Anton Hagenbeek </div>
</p>
</div>
<div>
<div>
<strong> ANTON HAGENBEEK, University Medical Centre Utrecht </strong><br />
For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah </div>
</div>
<p>…</p></div>
<!--END .post-content -->

</div>

<a class=

Read More+

Live Report from ASH:
Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?+

11th December 2007

christian geisler Live Report from ASH:<br />Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?” src=”http://www.audiomedica.com/img/asco/071211/christian_geisler.jpg” /<br /> Christian Geisler </div>
</p>
</div>
<div>
<div>
<strong> CHRISTIAN GEISLER, Rigshospitalet, Copenhagen </strong><br />
Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details </div>
</div>
<p>…</p></div>
<!--END .post-content -->

</div>

<a class=

Read More+

Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes+

10th December 2007

Pierre Fenaux

PIERRE FENAUX, Paris 13 University
Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University

…

Read More+

New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura+

9th December 2007

Terry Gernsheimer

TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial

…

Read More+

14 posts remaining + Load More